New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON, July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology ...
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including ...
DNA testing for the two most common types of cancer-causing HPV detects the most risky cervical lesions better than liquid-based cytology, data from the ATHENA trial indicate. Detecting HPV-16 and HPV ...
BOSTON, July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology business of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback